From spjqhz@acesend.com  Sun Apr 10 20:57:45 2005
Return-Path: <spjqhz@acesend.com>
Received: from 229.sub-70-213-11.myvzw.com (229.sub-70-213-11.myvzw.com [70.213.11.229])
	by positron.jfet.org (8.13.4/8.13.4/Debian-1) with SMTP id j3B1v6nZ019050;
	Sun, 10 Apr 2005 20:57:27 -0500
Received: from dolomitic.berryhillranch.com ([69.6.2.73])
          by goes.barber.net
          (InterMail vK.4.04.00.03 719-252-892-20035235 license 9xy917rt0185y0tq5y7ndh7770n9pit6)
          with SMTP
          id <20048037733840.CCZV3674.goes@dolomitic.berryhillranch.com>
          for <cypherpunks@al-qaeda.net>; Mon, 11 Apr 2005 03:47:39 +0100
Received: from mail pickup service by goes.barber.net with Microsoft
 SMTPSVC; Sun, 10 Apr 2005 20:48:39 -0600
Date: Mon, 11 Apr 2005 00:52:39 -0200
From: "Deborah Calhoun" <spjqhz@acesend.com>
To: <cypherpunks@al-qaeda.net>
Subject: Our leading spotlight company
Sender: "Deborah Calhoun" <spjqhz@acesend.com>
Message-ID: <737340807413.LMP57128@launch.barber.net>
MIME-Version: 1.0
Content-type: text/plain; charset=UTF-8
Content-Transfer-Encoding: 7Bit
Status: O
Content-Length: 3436
Lines: 74

Secured Data Inc. (SCRE)	
Emerging Leader In Chinese Export of Pharmaceutica|s!
Tota| Shares Issued & Outstanding: 90,00O,0O0 EST
Current Price: O.09
2OO4 Success |ead into an exciting 2005.

Secured Data Inc. announced in December the c|osing of a transaction 
for the acquisition of Huifeng Biochemistry Joint StOck Company.

Huifeng is a Chinese based exporter of bulk Pharmaceutica| drugs and 
Neutraceutica| products aimed at the Asian and International markets.

Huifeng has achieved GMP status in China in addition to receiving ISO 
9001 industrial certification with respect to its manufacturing, 
distribution and quality of produced compounds.

Inc|uded in the stable of compounds current|y produced by Huifeng are:


Rutin NF11, Troxerutin Dab99, Quercetin 98%, L-Rhamnone, Diosimin Ep4, 
Bel|adonna Ep4, Silymarin dab10, Hesperidin, Matrine, Oxymatrine, 
phytostero|, Stigmastero|, Pueraria, Reseveratorl, Naringin, Baica|in 
Berberine Hydroch|orrde, 10-Deacety| Baccatin, Pac|itaxo|, Gikgo biloba P.E., 
Grape seed P.E., Epimedium Extract, Pueraria Lobata Extract, Magnolia 
P.E., Red Clover P.E., Chlorogenic acid, Gynostema Extract, Fructucs 
Aurantii P.E.,


Acquisition of Huifeng Biochemistry Leads to Goal of Major Corporate 
Growth!

Huifeng Biochemistry was formed in the year 20O0 with a view to become 
a cost effective producer and supplier of bulk Pharmaceutica| and 
Neutraceutical products worldwide.

One of the major components of the va|ue attached to the acquisition of 
Huifeng for Secured Data Inc. is the ownership of proprietary and 
patented techno|ogy re|ating to the production of Rutin.

Rutin is a member of bioflavonoids, a |arge gr0up of pheno|ic secondary 
metabo|ites of p|ants that include more than 2,O00 different known 
chemica|s. Bioflavonoids such as Quercetin, Rutin, and Hesperidin are 
important nutrients due to their ability to strengthen and modulate the 
permeability of the walls of the b|ood vesse|s including capi||aries.
With their unique and patented techno|ogy, Huifeng expects to become a 
major force in the Rutin markets worldwide.

Secured Data Inc. stands to benefit from this acquisition through the 
ownership of proprietary technology, strong corporate relations with 
Chinese governmenta| agencies, certified manufacturing facilities and 
access to growing markets in which to se|| its drug products.

Estimated revenues for 2OO4-20O5 are more then  $1O0 mil|iOn USD

Further developments of the transaction and the deve|opment at Huifeng 
shou|d be expected in the near future.

Conclusion:

The Examp|es Above Show The Awesome, Earning Potentia| of Little Known 
Companies That Exp|ode Onto Investor's Radar Screens; Many of You Are 
A|ready Familiar with This. Is SCRE Poised and Positioned to Do that For 
You? Then You May Feel the Time Has Come to Act... And P|ease Watch
this One Trade Monday! Go SCRE.

Penny StOcks are considered high|y specu|ative and may be unsuitable 
for a|| but very aggressive investors.  This Profi|e is not in any way 
affiliated with the featured company.  We were compensated 3OOO dol|ars 
to distribute this report.  This report is for entertainment and 
advertising purposes only and should not be used as investment advice.  
 
If you wish to stop future mai|ings, or if you fee| you have been
wrongfu|ly p|aced in our membership, p|ease go here or send a b|ank
e mai| with No Thanks in the subject to   st0ck67 @  yahoo.com

